Association study of CD14 polymorphism with myocardial infarction in a Japanese population

Japanese Heart Journal

Volumn 44, Issue 5, 2003, Pages 613-622

  Hohda, Shigeru ^a,b   Kimura, Akinori ^b   Sasaoka, Taishi ^a,c   Hayashi, Takeharu ^b   Ueda, Kazuo ^b   Yasunami, Michio ^b   Okabe, Masaaki ^d   Fukuta, Naoto ^a   Kurosawa, Toshiro ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Shimizu Kohsei Hospital   (Japan)

^d Tachikawa General Hospital   (Japan)

Author keywords

CD14 receptor; Genetic risk factor; Myocardial infarction; Polymorphism

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALDOSTERONE SYNTHASE; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CD14 ANTIGEN; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; FIBRINOGEN B BETA CHAIN; GLYCOPROTEIN IIIA; LYMPHOTOXIN; THYMINE; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HABITUATION; HEART INFARCTION; HOMOZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE;

AGED; ANTIGENS, CD14; ASIAN CONTINENTAL ANCESTRY GROUP; E-SELECTIN; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 4344610941     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.613     Document Type: Article

References (33)

1. Forrester JS. Role of plaque rupture in acute coronary syndromes. Am J Cardiol 2000; 86: 15J-23J.
2. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000; 86: 3J-9J.
3. Shea S, Ottman R, Gabrieli C, et al. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984; 4: 793-801.
4. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Eng J Med 1994; 330: 1041-6.
5. Wenzel K, Blackburn A, Ernst M, et al. Relationship of polymorphism in the renin-angiotensinogen converting system and in E-selectin of patients with early severe coronary heart disease. J Mol Med 1997; 75: 57-61.
6. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for renin-angiotensinogen system-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
7. Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-10.
8. Wang XL, Sim AS, Badenhop RF, et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-5.
9. Behague I, Poirier O, Nicaud V, et al. Beta-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Circulation 1996; 93: 440-9.
10. Zito F, Di Castelnuovo A, Amore C, et al. Bcl l polymorphism in the fibrinogen β-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. Arterioscler Thrombo Vasc Biol 1997; 17: 3489-94.
11. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.
12. Serrato M and Marian AJ. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995; 96: 3005-8.
13. Kluijtmans LA, van den Heuvel LP, Boers GH, et al. Molecular genetics analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
14. Yamada Y, Ichihara S, Fujimura T, et al. Identification of G944→T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism 1998; 47: 177-81.
15. Yokota M, Ichihara S, Lin TL, et al. Association of a T 29→C polymorphism of the transforming growth factor beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-7.
16. Hautanen A, Toivanen P, Manttari M, et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation 1999; 100: 2213-8.
17. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650-4.
18. Hubacek JA, Rothe G, Pit'ha J, et al. C(-260)T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218-20.
19. Kimura A and Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. 1992 In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991 Vol.1, Oxford University Press, 1991, Oxford, 419-25.
20. Sasaoka T, Kimura A, Honda S, et al. Polymorphisms in the platelet-endothelial cell adhesion molecule-1 (Pecam-1) gene, Asn563Ser and Gly670Arg, associated with myocardial infarction in the Japanese. Ann N Y Acad Sci 2001; 947: 259-70.
21. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999; 340: 115-26.
22. Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998; 31: 1217-25.
23. Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-25.
24. Loppnow H, Libby P, Freudenberg M, et al. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immunol 1990; 58: 3743-50.
25. Chow JC, Young DW, Golenbock DT, et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-92.
26. Setoguchi M, Nasu N, Yoshida S, et al. Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim Biophys Acta 1989; 1008: 213-22.
27. Zhang DE, Hetherington CJ, Tan S, et al. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem 1994; 269: 11425-34.
28. Shimada K, Watanabe Y, Mokuno H, et al. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. J Am Coll Cardiol 2000; 86: 683-4.
29. Unkelbach K, Gardemann A, Kostrzewa M, et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thrombo Vasc Biol 1999; 19: 932-8.
30. Zee RY, Lindpaintner K, Struk B, et al. A prospective evaluation of the CD14 C (-260) T gene polymorphism and risk of myocardial infarction. Atherosclerosis 2001; 154: 699-702.
31. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916-23.
32. Jarvelainen HA, Orpana A, Perola M, et al. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001; 33: 1148-53.
33. Kono H, Wheeler MD, Rusyn I, et al. Gender differences in early alcohol-induced liver injury: role of CD14, NF- κB, and TNF- α. Am J Physiol Gastrointest Liver Physiol 2000; 278: G652-61.